Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. 'Time Saved' As a Demonstration of Clinical Meaningfulness and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings 2023-01-01
  2. Demonstration of age-related blood-brain barrier disruption and cerebromicrovascular rarefaction in mice by longitudinal intravital two-photon microscopy and optical coherence tomography 2021-02-05
  3. Alzheimer's disease: a new evidence for common epitopes between microtubule associated protein Tau and paired helical filaments (PHF): demonstration at the electron microscope level by a double immunogold labelling 1988-01-01

Studies

3 studies carry this tag.

Date range

1988 to 2023

Top journals

  • American journal of physiology. Heart and circulatory physiology 1
  • The journal of prevention of Alzheimer's disease 1
  • Virchows Archiv. A, Pathological anatomy and histopathology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. 'Time Saved' As a Demonstration of Clinical Meaningfulness and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. The journal of prevention of Alzheimer's disease 2023-01-01 Treatments

    In Alzheimer's disease (AD) clinical trials, disease-modifying therapies are expected to slow the rate of disease progression.

  2. Demonstration of age-related blood-brain barrier disruption and cerebromicrovascular rarefaction in mice by longitudinal intravital two-photon microscopy and optical coherence tomography

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. American journal of physiology. Heart and circulatory physiology 2021-02-05 Brain scans and imaging

    Age-related blood-brain barrier (BBB) disruption and cerebromicrovascular rarefaction contribute importantly to the pathogenesis of both vascular cognitive impairment and dementia (VCID) and Alzheimer's disease (AD).

  3. Alzheimer's disease: a new evidence for common epitopes between microtubule associated protein Tau and paired helical filaments (PHF): demonstration at the electron microscope level by a double immunogold labelling

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Virchows Archiv. A, Pathological anatomy and histopathology 1988-01-01 Drug development

    Paired helical filaments (PHF) are neuronal landmarks of Alzheimer's disease.

All topic tags with their study counts